These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 2906281

  • 1. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA, Tötterman TH.
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [Abstract] [Full Text] [Related]

  • 2. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I.
    N Engl J Med; 1987 Jan 01; 316(1):15-22. PubMed ID: 2946953
    [Abstract] [Full Text] [Related]

  • 3. Activated T cells in Graves' disease before treatment.
    Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D.
    Clin Exp Immunol; 1985 Feb 01; 59(2):377-82. PubMed ID: 3156702
    [Abstract] [Full Text] [Related]

  • 4. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
    Paggi A, Amoroso A, Ferri GM, Mariotti A, Pellegrino C, Afeltra A.
    Eur Rev Med Pharmacol Sci; 1998 Feb 01; 2(1):11-9. PubMed ID: 9825565
    [Abstract] [Full Text] [Related]

  • 5. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC, Rastogi B, Iwatani Y, Iitaka M, Row VV, Volpé R.
    Clin Invest Med; 1987 Jul 01; 10(4):337-44. PubMed ID: 2888555
    [Abstract] [Full Text] [Related]

  • 6. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
    Aust G, Lehmann I, Heberling HJ.
    Exp Clin Endocrinol Diabetes; 1996 Jul 01; 104(1):50-8. PubMed ID: 8750571
    [Abstract] [Full Text] [Related]

  • 7. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy.
    Corrales JJ, López A, Ciudad J, Orfao A.
    J Biol Regul Homeost Agents; 2000 Jul 01; 14(3):193-9. PubMed ID: 11037052
    [Abstract] [Full Text] [Related]

  • 8. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL.
    J Immunol; 1985 Sep 01; 135(3):1778-85. PubMed ID: 2991373
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK, Doyle LV, Bradley EC.
    J Immunol; 1986 Nov 01; 137(9):2814-22. PubMed ID: 2944965
    [Abstract] [Full Text] [Related]

  • 10. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ, López A, Ciudad J, Mories MT, Miralles JM, Orfao A.
    J Endocrinol; 1997 Dec 01; 155(3):491-500. PubMed ID: 9487994
    [Abstract] [Full Text] [Related]

  • 11. Correlation of activated monocytes or B cells with T lymphocyte subsets in patients with Graves' disease.
    González A, Calleja A, Santiago E, De Miguel C, López-Zabalza MJ, López-Moratalla N.
    Int J Mol Med; 1998 Jan 01; 1(1):95-103. PubMed ID: 9852205
    [Abstract] [Full Text] [Related]

  • 12. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K.
    Bone Marrow Transplant; 1986 Dec 01; 1(2):121-32. PubMed ID: 2971408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
    Kansas GS, Wood GS, Fishwild DM, Engleman EG.
    J Immunol; 1985 May 01; 134(5):2995-3002. PubMed ID: 3156924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J, Karsenty G, Bouchard P, Schaison G.
    Clin Exp Immunol; 1984 Sep 01; 57(3):633-8. PubMed ID: 6147216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ.
    J Manipulative Physiol Ther; 1994 May 01; 17(4):219-27. PubMed ID: 8046277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.